WAM
MDT icon

Worth Asset Management’s Medtronic MDT Stock Holding History

Worth Asset Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,950
Closed -$172K – 279
2023
Q2 		$172K Sell
1,950
-175
-8% -$15.1K 0.13% 90
2023
Q1 		$171K Sell
2,125
-160
-7% -$13K 0.13% 97
2022
Q4 		$178K Buy
2,285
+551
+32% +$44.7K 0.12% 80
2022
Q3 		$140K Sell
1,734
-78
-4% -$7.01K 0.1% 74
2022
Q2 		$163K Hold
1,812
– – 0.11% 89
2022
Q1 		$183K Buy
+1,812
New +$191K 0.12% 79

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Worth Asset Management's MDT Position: Q3 2023 in Review

Worth Asset Management sold out of Medtronic (MDT) in Q3 2023, closing a stake of 1,950 shares — an estimated $172K sold.

Worth Asset Management first reported a position in MDT in Q1 2022 and held it in 6 quarters. The position peaked at $183K in Q1 2022. 1,971 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Worth Asset Management reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • Worth Asset Management sold 1,950 Medtronic shares in Q3 2023, an estimated $172K.
  • Worth Asset Management first reported a position in Medtronic in Q1 2022 and held it in 6 quarters.
  • Worth Asset Management's Medtronic position peaked at $183K in Q1 2022.
  • 1,971 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Worth Asset Management's 13F filing for Q3 2023, filed 11 Oct 2023.